Undergraduate Journal Cardiovascular Medicine 2012

Published on January 2017 | Categories: Documents | Downloads: 44 | Comments: 0 | Views: 220
of 28
Download PDF   Embed   Report

Comments

Content

The Undergraduate Journal of

Cardiovascular Medicine
1st edition, november 2012
www.heartsoc.co.uk

The future of
cardiovascular
medicine?
cardiac regeneration
medicine: synthetic
cardiac grafts

National Undergraduate Cardiovascular Conference 2012
Approved by the British Cardiovascular Society, the first ever National Undergraduate
Cardiovascular Conference will be held at Southampton General Hospital on
Saturday, 3rd November 2012. Targeted at undergraduates and junior doctors, this
conference aims to:
•Provide an insight into career options and the differences between the various
cardiovascular specialties.
•Highlight important and interesting recent research findings that relate to each
specialty.
•Provide an opportunity for students involved in cardiovascular research to present
their work either orally or as a poster to an audience of interested students and a jury
of clinicians and researchers.
•Provide a networking opportunity, aiming to increase collaboration between
students from different universities with a view to creating a national cardiovascular
community for undergraduates and a circuit of educational, skill building and career
development events across the country.
We expect wide participation in this exciting event from many students at universities
around the UK and abroad.
The organising committee would like to thank the British Cardiovascular Society
and the Cardiology Department at Southampton General Hospital for their help and
support during the organisation of this conference. We would also like to thank the
following sponsors for making this event possible:


 

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

foreword
Cardiology remains one of the most exciting
and rapidly evolving specialties in the whole
of medicine and, as a result, always tends to
attract high quality trainees. This is
fortunate as cardiovascular disease accounts
for a large proportion of the patients seen
both in hospital and in primary care and
remains one of the biggest killers in modern
Western society.
It was as a 3rd year medical student that I first became attracted to Cardiology as a
specialty and I hope this national undergraduate cardiovascular conference will serve
as a catalyst for many of you to pursue a similar path. Cardiology has always been a
fascinating and rewarding specialty. The clinical and research developments in
cardiology have been massive and eclipsed most other specialties. There is no
indication that this rapid pace of development in cardiology is likely to slow down
over the duration of your own careers in medicine.
I must congratulate the organisers of the National Undergraduate Cardiovascular
Conference 2012 for putting together such an excellent programme spanning both
research and a spectrum of clinical specialties in modern cardiovascular care. It will
give you a valuable insight into why cardiovascular medicine remains one of the most
innovative, challenging and, above all, rewarding areas of modern medicine. I am
sure you will have a fantastic day.

Iain A Simpson MD FRCP FACC FESC
Consultant Cardiologist and President, British Cardiovascular Society

3

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

President

the committee

Alexander Bush
Speakers &
Seminars

Speakers &
Seminars

Treasurer &
Sponsorships

Hwai Jing Hiew

Qian Yue Tan

Michael Stephanou

Research
Presentation

Research
Presentation

Publications &
Media

Hamed Hajiesmaeili

Stelios Iacovides

Ka Ho Oscar Chiu

Committee Support

4

Aman
Chungh

Stephanie
Kwok

Luke
Michael

Claire
McAleer

Avinash
Segaran

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

contents

Programme

6

Speakers Biographies

8

Abstracts:
• The Panel

12

• Oral Presentations

14

• Poster Presentations

16

Delegate Information

24

5

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

programme

6

08:00 – 09:00

Registration

09:00 – 09:15

Welcome

09:15 – 10:00

Keynote Address: Cardiac Regenerative
Medicine – Synthetic Coronary Grafts
-Professor Alexandar Seifalian

10:00 – 10:45

Electrophysiology
-Dr. Arthur Yue

10:45 – 11:15

Coffee/Poster Presentations

11:15 – 12:00

Percutaneous Coronary Intervention (PCI)
-Dr. Andrew Whittaker

12:00 – 12:45

Heart Failure, Basic Pacing and Devices
-Dr. Andrew Flett

12.45 – 13:45

Lunch/Poster Presentations

13:45 – 14:30

Oral Presentations

14:30 – 15:15

Non-invasive Cardiac Imaging
-Dr. Dhrubo Rakhit

15:15 – 16:00

Adult Congenital Heart Disease
-Dr. Aisling Carroll

16:00 – 16:15

Coffee/Poster Presentations

16:15 – 17:00

Cardiothoracic Surgery
-Mr. Nicola Viola

17:00 – 17:30

How to get there? Tips on CV writing and
getting the job
-Dr. Abdul-Majeed Salmasi

17:30 – 18:00

Closing and Prize Presentations

All the tools
you need...
With MDU
membership
you have
access to:

• Discounts on medical textbooks
• 24-hour freephone advisory helpline
• Elective planning support
• Educational support including medico-legal articles and publications
• Professional indemnity for your elective
• Sponsorship of student events and teams... and much more.
Keep up to date with the latest news, events, videos and photos from the MDU.
facebook.com/MDUstudent

youtube.com/medicaldefenceunion

@The_MDU

MDU. Supporting you all the way. the-mdu.com/studentm
The MDU always seeks to offer attractive benefits as part of membership and as such, from time to time, may add, withdraw or amend benefits at its discretion.
Visit the-mdu.com for the latest information of the benefits included in membership.
MDU Services Limited is registered in England 3957086. Registered Office: 230 Blackfriars Road, London, SE1 8PJ. © 2012 MDU Services Limited. ST/035x/0712

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

the speakers
Keynote Speaker: Professor Alexander Seifalian
Dr. Alex Seifalian is a Professor of Nanotechnology
and Regenerative Medicine at the Division of
Surgery & Interventional Science, University College
of London, UK. His breakthrough work in bypass
grafts for cardiovascular treatment saw the
Professor awarded the 2007 'Winner of The Overall
Cardiovascular Innovation Award' by the prestigious
Medical Futures Innovation Awards panel, while his
work on harnessing nanotechnology for implanted
devices has resulted in the development of 'NASA style' nanotechnology coatings for
bypass grafts used in heart and blood vessel surgery.
His research interests include development of nanomaterials, development of
cardiovascular implants, development of nanofluorescence particle including
quantum dots for localization and treatment of cancer, stem cells for development of
organs using tissue engineering, development of organs using biodegradation
nanomaterials and stem cells, including liver and intestine, hepatic microcirculation
and oxygenation using an optical technique, ischemia repercussion injury and
preconditioning. In fact, the team lead by Dr. Seifalian patented a nanocomposite
material that was used to create the first ever completely synthetic windpipe.

Dr. Arthur Yue
Dr. Yue is currently a consultant
cardiologist and electrophysiologist at
University
Hospital
Southampton.
Having trained in Oxford University, he
completed his specialty cardiology
training at Southampton University
Hospital and Oxford John Radcliffe
Hospital. His sub‑specialty interest
involves the diagnosis and management
of all forms of heart rhythm disorders and conditions associated with sudden cardiac
death. He is fully trained in the implantation and follow-up of pacemakers for
treatment of bradyarrhythmias, defibrillators (ICD) for prevention of sudden death,
and cardiac resynchronization therapy (CRT) devices for treatment of heart failure.
For catheter ablations, he utilizes both conventional techniques and
three‑dimensional mapping technologies to investigate and target complex
arrhythmic substrates.
(Adapted from: http://www.uhs.nhs.uk/ContactUs/Directoryofconsultants/DirectoryofconsultantsY/YueDrArthur.aspx)

8

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

the speakers
Dr. Andrew Whittaker
Dr. Whittaker is currently a 4th year Cardiology Specialty Registrar
training in Interventional Cardiology. From January 2013 he will be
the Interventional Cardiology Fellow at Wessex Cardiothoracic
Centre. He qualified from University of Leicester Medical School in
2000 and completed his PRHO and SHO training in Leicester. After
gaining MRCP he undertook a 3-year period of research in
cardiovascular medicine for which he was awarded a Doctorate in
Medicine. His research project was titled The Role of Endothelial
Progenitor Cells in the Aetiology and Pathogenesis of Coronary
Artery Disease. He subsequently entered Specialist Registrar
training in Cardiology and is currently enjoying his training in the Wessex Deanery.
His sub-specialty interest is Interventional Cardiology (percutaneous coronary and
valvular interventions). Dr. Whittaker maintains an interest in clinical research with
special interest in coronary artery disease pathophysiology, endothelial dysfunction
and repair, cardiovascular genetics, and cellular reparative mechanisms in
cardiovascular disease.

Dr. Andrew Flett
Dr. Flett is a recently appointed consultant in heart failure and devices commencing
February 2013 at University Hospital Southampton. He trained in advanced heart
failure management at the heart hospital in London and recently set-up the second
ultrafiltration service in the country.
His research interests are in cardiovascular magnetic resonance having developed a
pioneering method to quantify the myocardial extracellular space as British Heart
Foundation clinical research fellow. He is also the Vice chairman of the Society for
Cardiovascular Magnetic Resonance web committee. He has developed an online
CMR academy and authored several book chapters. He has presented his work at
national and international meetings and won 2 young investigator awards.

Dr. Dhrubo Rakhit
Dr. Rakhit graduated from Charing Cross
and Westminster Medical School in 1993
and trained as a Cardiologist in London.
He is a specialist in all types of
echocardiography, including 3D echo,
tissue Doppler, stress and contrast echo,
transoesophageal echocardiography (TOE)
and optimisation echo for patients with
pacing devices. He has presented his work
at a number of prestigious national and international meetings and completed his
PhD titled 'The Use of Echocardiography to Screen High-Risk Patients for Subclinical
Cardiac Disease in 2006. Dr. Rakhit has also developed the 3D TOE and stress echo
services within the trust and established the digital archiving system for echo.
(Adapted from: http://www.uhs.nhs.uk/ContactUs/Directoryofconsultants/DirectoryofconsultantsR/RakhitDrDhrubo.aspx)

9

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

the speakers
Dr. Aisling Carroll
Dr. Carroll is a consultant cardiologist
specialising in adult congenital heart disease at
Southampton General Hospital. She graduated
from National University of Ireland, Galway
and completed her sub-specialty Cardiology
Fellowships in adult congenital heart disease,
heart failure and cardiac transplantation at
Mayo Clinic, Minnesota, USA. She is a
prominent speaker having given many talks in
various cardiology and congenital heart disease
conferences.

Mr. Nicola Viola
At University Hospital Southampton, he is the surgical lead and certified specialist
for the extracorporeal life support (ECLS) program.
He has contributed to a number of peer-reviewed articles and several chapters in
surgical textbooks and is author of the award-winning textbook “Key Questions in
Cardiac Surgery”, now included in the surgical curriculum of the American
Association of Directors of Cardiothoracic Surgery Programs.
He has presented at national and international meetings on congenital cardiac
surgery and quality control.
(Adapted from: http://www.uhs.nhs.uk/ContactUs/Directoryofconsultants/DirectoryofconsultantsV/ViolaMrNicola.aspx)

Dr. Abdul-Majeed Salmasi
Dr. Salmasi is a Senior Research Fellow at the National Heart
and Lung Institute, Imperial College London and a Consultant
Cardiologist. He is the Director of Cardiovascular Teaching and
Training at NHS Brent.
He obtained his PhD in Medicine from St. Mary's Hospital
medical school (currently Imperial College London) and
continued his training in cardiology at St. Mary's Hospital,
London. He has edited four postgraduate textbooks in
Cardiology and till now published 50 original articles in the
cardiovascular filed.
He is a fellow of the European Society of Cardiology, Fellow of the American College
of Cardiology and a Fellow of the Faculty of Public Health at the Royal College of
Physicians of London. His main research interest is left ventricular hypertrophy and
the relation between hypertension and glucose intolerance, atrial fibrillation and
cardiovascular changes in autoimmune diseases.
(Adapted from: http://www1.imperial.ac.uk/medicine/people/a.salmasi/)

10

1
OxfOrd HandbOOk Of

CardiOlOgy
Second edition

‘A brilliant and
comprehensive review
of cardiology. It is
easily the best quick
reference guide in
cardiology available.’
- Cardiology News

Visit www.oup.com/uk/medicine
for more information and to order your copy

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
The core around which this conference is based is the cardiovascular research being
conducted by undergraduates around the country. This year, four students will be presenting
their research during an oral plenary session. Up to 20 more students will be presenting their
work as a poster. This represents a fantastic opportunity for undergraduates involved in
cardiovascular research to present their work to a national audience of interested students,
and to our faculty of leading cardiovascular researchers.

The Panel
Dr. Simon Corbett

Dr Corbett is a consultant cardiologist at University
Hospital Southampton. He is fully trained in all
aspects of coronary intervention including formative
experience with renowned pioneer and innovator, Dr
Antonio Colombo in Milan. Principal clinical
interests are the use of angioplasty to treat heart
attacks and the use of intra-vascular ultrasound and
pressure wires to assess and guide treatment of
coronary artery narrowings. My main research
interests are participation in multi-centre, randomised clinical trials and local research
projects evaluating the coronary pressure wire and measurement of platelet reactivity.

Professor Nick Curzen

Prof Curzen is a consultant cardiologist and
Professor of interventional cardiology at University
Hospital
Southampton.
He
specialises
in
percutaneous coronary and aortic valve intervention.
He is the co-editor of three cardiology textbooks
including the Oxford Textbook of Interventional
Cardiology as well as authors of 21 book chapters
and 120 peer-reviewed papers. He has won
numerous research prizes including the John Hart
Research Prize. He was the expert adviser on treatment of heart attack to Prime Ministers
Directive Unit in 2004 and he is currently the honorary secretary of the British
Cardiovascular Intervention Society.

Professor Huon Gray

Professor Gray is a consultant cardiologist with
interests in interventional cardiology. Trained as a
registrar in Brompton and St. George’s Hospital
London, Prof Gray has been working as a consultant
in University Hospital Southampton since 1989. He
has over 100 publications in various aspects of
cardiology and has won the ACCEA Gold Award in
2005. He has held a number of important posts
including the president of the British Cardiac Society
between 2003 and 2005.

12

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Dr. Paul Roberts

Dr Roberts is a consultant cardiologist at University
Hospital Southampton specialising in cardiac
rhythm management. He is an experienced
interventional electrophysiologist with particular
expertise in device implantation (pacemakers, ICDs,
and cardiac resynchronization devices) and catheter
ablation. He was appointed to European Heart
Rhythm
Association
Electrophysiology
Accredidation Committee in 2008 and is an active
participant in clinical research with over 130 published abstracts, 50 peer-reviewed
publications and has edited 2 books for the Royal College of Physicians and written 6 book
chapters.

 

Dr.
 Michael
 Griksaitis
 

Michael completed his undergraduate training at Newcastle University, and went on to
complete his Paediatric Membership in the Northern Deanery. He then took up a position in
Paediatric Cardiology at Southampton and then subsequently Paediatric Intensive Care, to
become a paediatric cardiac intensivist. His research interests and publications include
trauma physiology, specifically monitoring cardiac function and cardiac output during
haemorrhage and medical education. He has recently published a textbook on Paediatric
Cardiology, designed to combine the basic sciences with clinical skills for junior doctors
on PICU and Cardiology. Outside of work, Michael enjoys underwater photography and
surfing.


 
Dr.
 James
 Rosengarten
 

James is currently the Research Fellow in Cardiac Rhythm Management, based at University
Hospital Southampton. Under the supervision of Prof. Morgan and Prof. Hanson at the
University of Southampton, he is utilising engineering techniques to discover novel
biomarkers of sudden cardiac death risk. He is a Wessex specialist registrar in cardiology,
specialising in electrophysiology and devices. He has a strong interest in education and
training, from examining students at the University of Southampton, through to representing
Wessex trainees at a national level.

13

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Oral Presentations
Is there a difference in self-reported quality of life between affected and unaffected paediatric cardiac
patients?
Name: Revati Kumar
University/ Trust/ Department: University College London, United Kingdom
Project Type: Clinical
Project Field: Paediatric Cardiology
Authors: Revati Kumar, Dr. Sara O'Curry, Ms. Holly Clisby, Dr Juan Pablo Kaski
Abstract
Background: A well-documented effect of suffering from a chronic condition is the impact on the patient’s healthrelated quality of life. However, for paediatric conditions, literature is currently divided. The relative rarity of the
conditions means that there is a scarcity of information. Aim: The purpose of this study was to evaluate whether
affected children self-reported a difference in quality of life when compared to unaffected children. Methods: 83
children between the ages of 8 and 18 presenting to the heart function, hypertrophic cardiomyopathy and inherited
arrhythmia clinics at Great Ormond Street Hospital formed the study population. The tools used to measure quality of
life were the PedsQL Generic Core Scales 4.0 and the PedsQL Cardiac Module 3.0, well-established and validated
questionnaires. In addition, a subgroup analysis within the affected cohort sought to investigate whether the severity
of the condition affected quality of life. Results: Results indicated that affected children experience a lower quality of
life than unaffected children in terms of their physical capabilities (p=0.035). No difference was demonstrated
between the cohorts in terms of psychosocial functioning (p=0.071). The subgroup analysis indicated no difference in
quality of life between the groups; further research with larger sample sizes may be necessitated in order to validate
these findings. Conclusions: The findings indicate that although affected children have significantly lower physical
abilities than unaffected children, they are currently receiving excellent psychological support to help them cope with
their illness, and this should be maintained.
Effect of remote ischaemic conditioning (RIC) on myocardial infarct size in STEMI patients
undergoing primary PCI
Name: Fiona Chan
University/ Trust/ Department: University College London, United Kingdom
Project Type: Clinical
Project Field: Cardiovascular Clinical Trial
Authors: Fiona Chan, Steven White, Derek M Yellon, Derek J Hausenloy
Abstract
Background: Despite optimal therapy, patients with a ST-elevation myocardial infarction (STEMI) still experience
significant morbidity and mortality. Remote ischaemic conditioning (RIC) may be a novel therapeutic strategy for
improving outcomes in STEMI patients. In RIC, cardioprotection is elicited by serially inflating and deflating a blood
pressure cuff on the upper arm to induce cycles of non-lethal ischaemia and reperfusion. In ERIC-STEMI, we
investigate whether RIC could reduce MI size in patients undergoing primary percutaneous coronary intervention
(PPCI). Methods: The ERIC-STEMI is an ongoing single-centre, single-blinded randomised controlled clinical trial
that investigates whether RIC reduces MI size and improves myocardial salvage in STEMI patients undergoing PPCI.
Patients with suspected STEMI are recruited on arrival at the PPCI centre, then randomised to receive either RIC or
control. In the RIC protocol, a blood pressure cuff is inflated to 200mmHg for 5 min then deflated for 5 min, a cycle
repeated 4 times. Control patients have a deflated cuff for 40 minutes. Blood samples are taken for measurement of
serum Troponin-T at the time of PPCI and 6, 12, 24 and 48 hrs following PPCI. A 48hr area under the curve (AUC) was
calculated as a measure of MI size. Patients also have cardiac MRI at discharge and at 6 months to assess MI size,
myocardial salvage, cardiac remodelling and function. Results: As of August 2012, 180 patients have been recruited.
An interim analysis of the blood results for 114 patients (n=54 RIC; n=60 control) revealed that RIC resulted in 23%
reduction in 48hr AUC TroponinT (71,518 ng/L (±7,616) with RIC versus 93,669 ng/L (±7,969) with control;
p=0.047). Conclusions: In this interim analysis of 114 patients of the ERIC-STEMI study, it appears that STEMI
patients randomised to receive RIC prior to PPCI had a 23% smaller MI size when compared to control patients.

14

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
The role of circulating endothelial precursor cells in the development of arteriovenous fistulae used
in haemodialysis
Name: Sonul Gajree
University/ Trust/ Department: University of Glasgow, United Kingdom
Project Type: Laboratory
Project Field: Renal Transplantation & Haemodialysis
Authors: Vesey A, Gajree S, Glen J, Aitken E, Clancy M
Abstract
Background: Circulating endothelial precursor cells (CEPC) are central to vasculogenesis. Maturation of an autologous
arteriovenous fistula (AVF) requires a large expansion of blood vessels and may depend on vasculogenesis. We aimed
to evaluate the role of CEPCs in AVF maturation. Methods: Patients with end-stage renal failure about to undergo
creation of an AVF were recruited. Whole blood was sampled immediately pre-op, 2 days post-op and 4 weeks post-op.
CEPC quantification was performed using a commercially available kit. Clinical and duplex ultrasound assessment was
undertaken immediately pre-op and 4 weeks post-op. CEPC titres were correlated with clinical and ultrasonographic
outcome data. Results: Interim data are summarised (n=15). There was a trend to lower baseline CEPC titres in
subjects compared to healthy controls. Smoking was significantly associated with lower baseline CEPC levels
(p<0.0005). Day 2 post-op levels of CEPC were significantly higher than pre-op levels (p=0.028). At the time of
writing, 5 patients had completed 4 week follow-up with 100% primary patency. Fistula diameter was positively
associated with immediate post-op rise in CEPC levels (p=0.015) but not with baseline CEPC levels. Conclusion:
Although these are early results, it has been demonstrated that a greater immediate post-op rise in CEPC count is
associated with a larger fistula diameter at 4 weeks. It is hoped that these results will be confirmed and translate to
clinical outcomes as more patients are recruited. A targeted pharmacological intervention designed to increase CPEC
levels (e.g. erythropoetin) and potentially improve AVF patency could then be tested.
What is the angiographic significance of ‘reciprocal’ ST segment depression in ST elevation
myocardial infarction?
Name: Charles Johnson
University/ Trust/ Department: University of Sheffield, United Kingdom
Project Type: Clinical
Project Field: Acute STEMI
Authors: C Johnson, S Brown, S Turton, A Sultan, R Orme, C Jackson, D Tayler, A Morton, J Gunn
Abstract
Background: ST elevation myocardial infarction (STEMI) is frequently associated with ‘reciprocal’
electrocardiographic ST segment depression. For 30 years there has been debate about the significance and origin of
this finding. The advent of primary angioplasty for STEMI allows us to re-examine the question. Method: We analyzed
the ECGs and angiograms of patients presenting to the primary angioplasty service of our hospital with STEMI
between June and December 2009. STEMI was defined as characteristic chest pain with ST elevation (STE) ≥1mm in
≥2 limb leads or ≥2mm in ≥2 contiguous chest leads, and reciprocal change as ≥1mm ST depression in the inferior
leads for anterior STEMI, and in the anterior leads for inferior STEMI. We measured the aggregate magnitude of STE
in each territory. We determined the extent of angiographic disease, both ‘culprit’ (ipsilateral) and ‘bystander’
(contralateral), in terms of the number of coronary arteries and segments affected, the SYNTAX scores, and vessel
dominance. Results: Of 188 patients, 70% were male, the mean age was 63.4 years, 95 had anterior and 93 inferior
STEMI. Reciprocal change was seen in 39% of anterior and 46% of inferior STEMIs. The magnitude of STE for inferior
STEMIs was 81% greater for cases with reciprocal change than for those without (p<0.001); and for anterior STEMIs it
was 27% greater (p=0.05). There was a correlation between ipsilateral maximum STE and contralateral maximum ST
depression for inferior, but not anterior, STEMI. There was no relationship between reciprocal change and
contralateral coronary artery disease (vessels, segments or SYNTAX score) for either anterior or inferior STEMIs.
Conclusion: The magnitude of reciprocal ST segment depression in STEMI is related to the magnitude of STE in the
culprit territory, and is unrelated to the presence or extent of non-culprit disease. Reciprocal change probably reflects
the size of the index STEMI itself.

15

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Poster Presentations
Prevention of stroke following a transient ischaemic attack
Name: Zenab Sher
University/ Trust/ Department: King’s College London, United Kingdom
Project Type: Audit
Project Field: Vascular Medicine
Authors: Zenab A Sher
Abstract
Introduction: In the UK, stroke accounts for 11% of deaths. A Transient Ischaemic Attack (TIA) is a neurological emergency, caused by risk factors
for stroke. Its clinical presentation includes unilateral hemiplegia, hemiparesis, coordination problems and speech and visual disturbances,
depending on the location of the lesion. The patient usually recovers from these symptoms within a day, unlike a stroke which may lead to
permanent disablement. The risk of developing stroke after a TIA is greatest in the first 48 hours following onset of symptoms. Intervention and
treatment after a TIA can help reduce this from 10% to much lower in the highest risk patients. Based on the ABCD2 scoring system, a high risk
patient is someone with a score of >4. Aim: To see if NICE guidelines are met appropriately – are all high risk patients seen by a specialist within 24
hours of symptom onset? Methods: Retrospective data analysis of consultation outcomes and delay to treatment for TIA patients at the stoke unit, in
April - July in 2010. Results: 37 patients were seen in the TIA clinic, 46% of which were diagnosed as TIA. The remaining 54% presented with
stroke-like symptoms which were other causes. 88% of the TIA patients were treated with Aspirin, whilst the remainder 12% were already on
warfarin. Of the TIA patients, 47% were classified as ‘high risk’ of stroke as they had an ABCD2 score of 4 or more. From the high risk patients,
87.5% were seen in clinic within 24 hours of symptom onset. Conclusion: A considerably high number of patients were seen by a specialist within
the recommended time frame based on NICE Guidelines, however not all patients are referred within the 24 hours. Telephone triaging, referrer
education and raising public awareness of stroke symptoms can help improve this.
The use of atrial fibrillation cycle length as a predictor of ablation success
Name: Alexandra Hanlon
University/ Trust/ Department: King's College London, United Kingdom
Project Type: Article
Project Field: Atrial fibrillation ablation
Authors: Alexandra Hanlon
Abstract
The current policy to ablate only those patients with paroxysmal AF (duration <7 days) is too excluding, and the use of AF cycle length (AFCL) is
proposed as the method of patient selection. Longer AFCL is known to reflect reduced AF complexity, and the current study shows that a surface
ECG recorded intra-f wave duration of >142ms has a specificity of 92.9% and sensitivity of 69.7% in predicting successful termination of persistent
(>7 days) AF at ablation, with success being defined as maintenance of sinus rhythm without pharmacological antiarrhythmic treatment for more
than 12 months. Furthermore, an AFCL of >142ms in conjunction with an AF duration of <21 months has a 100% specificity in predicting
procedural termination of AF. Longer AF cycle length also correlates with better response to antiarrythmic therapy and DC cardioversion. Therefore,
it is proposed that surface ECG AFCL should be the method of patient selection for ablation, in order to include those patients with long AF
duration, but who may still undergo successful ablation.
A comprehensive approach to the reduction of device-related infection in a cardiology department
Name: Kirsty Bromage
University/ Trust/ Department: University of Bristol, United Kingdom
Project Type: Audit
Project Field: Implantable Cardiac Devices
Authors: Richard Bond, Daniel Augustine, Kirsty Bromage, Lara Howells, Richard Kilbey, Stuart Walker, Mark Dayer
Abstract
Introduction: Infection is a serious complication of cardiac device implantation (CDI). Few large-scale clinical audits have been carried out, meaning
estimations of risk may not reflect current practice. Aims: To quantify infection rates of CDI procedures carried out in a district general hospital
before and after the instigation of a comprehensive infection control policy. Methods: Retrospective analysis of outcomes for all CDIs from January
2007 to May 2012. Following a spike in infection rates, a series of changes were introduced during June 2011 and beyond in an effort to reduce
device-related infections. These comprised: Chloroprep instead of povidone-iodine/chlorhexidine, a pre-pacemaker shower, routine venograms
stopped, Vicryl Plus in place of Vicryl, any instruments with rust removed from use, Flucloxacillin for 48h, MSSA screening for high risk cases
(September 2011) and all cases (May 2012), theatre air filters and flows replaced/reviewed, Chlorhexidine nail brushes. Results: Prior to the review
of practice, 1948 CDIs were carried out, 35 of which resulted in device-related infections (1.8%). We identified two spikes in infection rates that were
significantly higher than our long-term infection rates: April-July 2010 (4.8%, Fisher’s exact test p=0.019) and February-June 2011 (3.8%, Fisher’s
exact test p=0.043). Since the comprehensive review of practice was implemented, there has only been 1 infection within 3 months of device
implantation out of the 318 cases performed between July 1st 2011 and 25th May 2012 (to allow for 3 months of follow-up): a rate of 0.3%. Although
this value is not significantly lower than our long-term rates (Fisher’s exact test, p=0.0511), it is significantly lower than the rate between February
and June 2011 (Fisher’s exact test, p=0.004). Conclusion: A thorough review of practice had the impact of reducing device-related infection.
Whether this will result in a durable and significant reduction in device-related infection remains to be seen.

16

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Coronary artery bypass grafting with Y-type saphenous vein: a case report highlighting the associated intra-operative benefits
Name: Iheukwumere Duru
University/ Trust/ Department: Manchester Medical School - University Hospital South Manchester, United Kingdom
Project Type: Case Report
Project Field: Coronary Artery Bypass Graft
Authors: I Duru, B Krishnamoorthy, WR Critchley, JE Fildes, N Yonan
Abstract
The long saphenous vein (LSV) is the predominant conduit utilised in coronary artery bypass graft (CABG) surgery, and can be retrieved via
endoscopic vein harvesting (EVH). Whilst EVH is associated with significantly greater recovery, wound healing and cosmetic appearance than the
traditional open vein harvesting technique, the long-term outcome has been questioned. Retrieval of the LSV has been associated with elevated risk
of bleeding in the tunnel during harvesting. This complication is even more distinct when a branch of the Y-type, anatomical variant of the LSV is
dissected and cauterised, due to the size of the vessel being cut. However, we demonstrate a case in which the Y-type variant of the LSV was instead
harvested and successfully utilised as a conduit. We therefore present the benefits associated with our approach. The postoperative results of this
case were compared to the outcome of 5 other patients, in whom the same anatomical variant of the LSV was dissected and cut by diathermy. Our
findings indicate that harvesting, rather than cauterising the Y-type vessel, resulted in fewer complications, including intraoperative bleeding. This
further reduced the operating time and did not necessitate the conversion to either open or bridging techniques in order to extract the vessel.
Renal function after mitral valve surgery performed with minimally invasive vs. conventional sternotomy approach
Name: Aleksandra Szczap
University/ Trust/ Department: University of Bristol, United Kingdom
Project Type: Audit
Project Field: Cardiac surgery
Authors: A Szczap, F Ciulli, G Asimakopoulos
Abstract
Background: Patients undergoing mitral valve surgery frequently sustain renal injury. Using plasma creatinine and the Cockroft-Gault formula to
estimate creatinine clearance (eCrCl), this study examines the hypothesis that minimally invasive mitral valve repair (MIMVR) is associated with
lesser degree of renal injury as compared with mitral valve repair (MVR) through sternotomy. Methods: This study evaluates data from all isolated
MVRs performed by two surgeons at our institution over a 3-year period. Data were collected using our prospective computerised database. In total,
there were 27 patients undergoing MIMVR and 170 patients undergoing MVR via sternotomy. Pre- and postoperative renal function at day 1, 4 and
7 was measured in the two groups. A secondary analysis with the populations divided into normal (eCrCl>50mL/min) and compromised preoperative renal function (eCrCl<50mL/min) was performed. Results: The two groups were similar with regards to age, gender, BMI, EuroSCORE,
angina and dyspnoea status, heart rhythm, left ventricular function, previous MIs, previous PCIs, diabetes, hypertension, smoking, pulmonary
disease, post-operative hospitalization, in-hospital death, post-operative heamofiltration and re-operation. (P>0.05). Renal function improved
significantly in both groups between pre-operatively and day 4 (P<0.05). There was no significant difference between groups at any time point in
terms of plasma creatinine levels pre- and post-operatively (values for MIMVR vs. MVR: 104.0 vs.105.5, 103.8 vs.104.0, 97.6 vs.100.0 and 103.4
vs100.0 umol/Lpre-operatively, on day 1, 4 and 7 respectively. P>0.05 for all) and creatinine clearance values (values for MIMVR vs. MVR: 62.7 vs.
64.5, 65.9 vs. 65.9, 70.5 vs. 70.4 and 61.3 vs. 69.0 ml/min pre-operatively, on day 1, 4 and 7 respectively. P>0.05 for all). The above observation
weres also valid for patients with reduced renal function pre-operatively. Conclusion: Overall, MVR does not result in singificant renal dysfunction.
There is no difference in renal function between patients undergoing MIMVR and MVR through sternotomy.
Is it possible to transmit sounds through the arterial system as a means of measuring blood pressure?
Name: Aisha Ali
University/ Trust/ Department: University of Manchester, United Kingdom
Project Type: Clinical
Project Field: Cardiology
Authors: Aisha Ali, Ewan Glassey, Sabeera Hussain
Abstract
Background: We aim to study how vibrations propagate along the arterial system and whether a new non invasive auscultative method of measuring
blood pressure in patients with arrhythmias is achievable. Method: 59 participants were included in the study, 18 had a normal BMI, 5 were
underweight and 31 were considered moderately obese. Measurements with a Doppler ultrasound were made at the brachial and radial arteries. A
sensitive microphone was mounted within the acoustic pathway of a stethoscope. Artificial sounds were produced at the subclavian artery and
detected by the three probes. Recordings were made on the left arm at three positions and two time intervals (cuff deflated and inflated.) The
difference of the amplitude of sound waves during cuff deflation and inflation (VD1-VI1) and the difference of the frequency (FI1-FD1) was
calculated. Results: A significant attenuation of sound was caused by the restriction of blood flow through the brachial and radial artery. The
microphone (VD1-VI1) was on average 66.45mV (95% CI 23.9-52.9.) The (FI1-FD1) recorded by the microphone during the two time intervals was
5.03Hz (95% Cl 7.6- 2.45.) Indicating that frequency of sound waves rises with cuff pressure. Conclusion: The attenuation of artificial sounds during
cuff inflation demonstrates that sound waves conduct through the arterial blood supply. This often coincides in time with the Korotkoff sounds.
These observations suggest that the production of regular rhythmic vibrations may be used in addition to Korotkoff sounds as an audible criterion
for recognising systolic pressure in patients with AF.

17

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Systolic arterial blood pressure is underestimated by auscultation compared with Doppler return-to-flow
Name: Sabeera Hussain
University/ Trust/ Department: University of Manchester, Blood Pressure & Heart Research Centre, Stockport NHS Foundation Trust, United
Kingdom
Project Type: Clinical
Project Field: Blood Pressure and Heart Research
Authors: S. Hussain, PS Lewis
Abstract
Introduction: Systolic blood pressure (SBP) is a key indicator of cardiovascular risk. It is therefore important to measure blood pressure accurately
to aid diagnosis and research. Methods: We studied 24 females and 32 males aged between 18-85 years. With subjects in a sitting position with their
left arm supported horizontal at level of shoulder, an A and D Medical UA 767 PC semi-automated blood pressure monitor was used to inflate and
deflate an appropriately sized cuff placed on the upper arm. Three readings were taken at 1 minute intervals. SBP was assessed, during cuff
deflation, by simultaneous auscultation of first Korotkoff sound (K1) heard over brachial artery with the bell of a Littmann stethoscope and by the
point of return of arterial blood flow measured by flat-bed Doppler probes placed over the brachial and radial arteries. Results: SBP measurements
differed significantly between methods. The pressure at which arterial blood flow returned at the brachial Doppler was 5.58mmHg higher than K1
(95% CI 1.85 to 9.32, p value= 0.004). The point of return of radial Doppler flow was 2.44mmHg higher than K1 (95% CI 0.66 to 4.21, p value =
0.008). Conclusion: The traditional auscultatory method of blood pressure measurement underestimates systolic blood pressure compared with
Doppler return-to-flow whether measured at the brachial or radial arteries, leading to potential errors in assessing cardiovascular risk and
monitoring patients' health.
Cardio renal arrhythmia study in haemodialysis patients using implantable loop recorders
Name: Sidharth Mohan
University/ Trust/ Department: University of Southampton, United Kingdom
Project Type: Clinical
Project Field: Cardiology
Authors: Paul R Roberts, Sidharth Mohan
Abstract
Background: End Stage Renal Disease (ESRD) occurs as the final stage of chronic kidney disease (CKD). It is at this stage that the kidneys cannot
function for themselves and an intervention is needed. This is most often in the form of dialysis. The increasing incidence of contributing factors
such as diabetes and hypertension has lead to an increase in the prevalence of ESRD. Existing research shows that these patients on dialysis have
been shown to have extremely high sudden cardiac death (SCD) rates. It is thought that arrhythmias may be the cause of SCD in this population.
Aims: This is an ongoing study that is being conducted to investigate the link between SCD and arrhythmias in patients with ESRD on dialysis, using
implantable loop recorders. Methods: The observational study is being conducted on patients who suffer from ESRD and also one or more of the
following; Poor left ventricular function as defined by an ejection fraction of less than 35% on echocardiography; Renal failure secondary to
diabetes; Significant left ventricular hypertrophy. All patients that are part of the study must have an implantable loop recorder fitted (ILR-Reveal
device). The ILR once implanted is set up to transmit information using the CareLink remote system. Transmitted information is displayed as an
ECG rhythm strip on the CareLink website. Results: The study is still in its recruitment phase and so far 5 patients have been recruited for the study.
The results so far have shown signs of atrial fibrillation for 20% of the participants. Conclusion: This study shows that it is possible to record the
cardiac activity on a regular continuous basis for ESRD patients who are on dialysis. This is vital for gaining an insight into the role of arrhythmia
and cardiac disease in mortality caused by dialysis.
The influence of a baseline heart rate on the final outcome in patients with acute myocardial infarction with ST-segment
elevation (STEMI)
Name: Srdjan Milanov
University/ Trust/ Department: Faculty of Medical Sciences, University of Kragujevac, Serbia
Project Type: Clinical
Project Field: Cardiology
Authors: Srdjan Milanov, Dusica Ognjanovic, Goran Davidovic, Violeta Iric-Cupic
Abstract
Background: Acute myocardial infarction is a clinical form of the coronary heart disease characterized by permanent damage or loss of cardiac
tissue. Heart rate is the most important determinant of myocardial oxygen demand and cardiac workload. Many prospective studies have shown
association between baseline heart rate levels less than 80 beats per minute(bpm) and better outcome in patients with STEMI. Purpose was to
investigate the influence of baseline heart rate levels on the final outcome in patients with STEMI. Methods: This largely prospective and partly
retrospective, population-type study, included 167 patients with STEMI treated in Coronary Unit,C linical center Kragujevac form January to June
2011. Baseline heart rate was defined according to the first ECG on the admission. All data are stored in a specially designed database, and
statistically analyzed in the SPSS for Windows with the methods of descriptive and analytical statistics. Results: In the observed group of 167
patients, 13(7,8%) patients died and 154(92,2%) patients survived. Of a total number of patients, 106(63,5%) had baseline heart rate levels less than
80 bpm (χ2-test;p=0,000). Among the survivors, 98(58,7%) patients had baseline heart rate levels less than 80 bpm and 56(33,5%) greater than 80
bpm; and in the group of patients with a fatal outcome 8(48%) patients had baseline heart rate levels less than 80 bpm and 5(3%) greater than 80
bpm. Mean baseline heart rate among the survivors was 79.27±21.59 (36-177) beats per minute. There was no statisticaly significant difference
between males and females. Conclusions: In the observed group of patients with STEMI baseline heart rate less than 80 bpm was associated with a
better outcome but a lot of patients who survived had heart rate greater than 80 bpm which indicates that heart rate had an important but not the
major role in a surviving of these patients.

18

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

“Obesity paradox” in patients with acute myocardial infarction

abstracts

Name: Stefan Simovic
University/ Trust/ Department: Faculty of Medical Sciences, University of Kragujevac, Serbia
Project Type: Clinical
Project Field: Cardiology
Authors: Stefan Simovic, Goran Davidovic, Violeta Iric-Cupic, Srdjan Milanov
Abstract
Introduction: Obese people live longer than their normal-weight counterparts. This phenomenon is called the “obesity paradox”. In obese patients
there is increased sympathetic activity and is responsible for increasing heart rate. Purpose was to investigate what was the impact of BMI on the
final outcome in patients with AMI and elevated heart rate, and whether there is the “obesity paradox” in these patients or not. Methods: This study
included 140 patients with STEMI, treated in Coronary Unit, Clinical center Kragujevac in the period from January 2001-June 2006.Heart rate was
calculated as the mean value of baseline and heart rate in the first 30 minutes after admission. BMI was calculated as the ratio of body weight in
kilograms and body height in squared meters, and classified according to WHO.All data were stored in a specially designed database, and
statistically analyzed in the SPSS using descriptive and analytical statistics. Results: In the observed group of patients, 40 (28,57%) patients died
and 100 (71,43%) patients survived. In both groups there was more than 75% of obese patients (76% among survivors and 82,5% of patients who
died). Compared to the mortality there was no statistically significant difference in the prevalence of obese patients (x2 test, p=403). The subgroup
of patients with heart rate greater than 80 bpm also showed that obesity affects mortality rate in patients with acute myocardial infarction. In this
subgroup there was 77,8% of obese patients among survivors and 81,1% among patients who died with no statistically significant difference (χ2-test;
p=0,689).
Conclusions: According to the mortality rate in this study there is a possibility that “obesity paradox” exists in patients with acute myocardial
infarction.
Heart rate – risk factor for morbidity and mortality in STEMI
Name: Stefan Simovic
University/ Trust/ Department: Faculty of Medical Sciences, University of Kragujevac, Serbia
Project Type: Clinical
Project Field: Cardiology
Authors: Stefan Simovic, Goran Davidovic, Violeta Iric-Cupic, Srdjan Milanov
Abstract
Introduction: Heart rate is the most important determinant of myocardial oxygen consumption and metabolic demands of heart. Many studies have
shown association between heart rate and increased cardiovascular morbidity and mortality, independently of other risk factors for atherosclerosis.
Purpose was to investigate the heart rate in patients with STEMI and to determine the influence of heart rate on mortality in these patients.
Methods: Study included 140 patients with STEMI, that were threated in Coronary Unit, Clinical center Kragujevac in the period from January
2001-June 2006. Study was partly prospective and partly retrospective. Heart rate was calculated as the mean value of baseline and heart rate in 30
minutes after admission. All data were stored in database, and statistically analyzed in the SPSS, using descriptive and analytical statistics. Results:
In the observed group of patients with acute myocardial infarction, 40 (28,57%)patients died and 100 (71,43%)patients survived. Of a total number
of patients, 109 (77,85%)had a heart rate levels greater than 80 bpm which was statistically significant (χ2-test; p=0,008).There was a significant
difference in heart rate levels on admission between survivors and patients who died (Mann Whitney U test; p=0,000),with a greater levels in
patients with fatal outcome (87,97±16,7 – survivors; 102,05±23,16 – fatal). There was no significant difference in heart rate levels according to age
and gender of patients. Both univariate [expB (95%CI)-1,040 (1,017-1,063); p=0,000)] and multivariate regression analysis [expB (95%CI)-1,076
(1,006-1,151); p=0,033)] singled out heart rate greater than 80 bpm as independent mortality predictor in these patients. Conclusions: Heart rate
greater than 80 bpm is a major risk factor for morbidity and mortality in patients with acute myocardial infarction, independent of other risk factors
for acute coronary syndrome.
Using FRET to characterise the actomyosin complex in cardiac muscle
Name: Lucia Chen
University/ Trust/ Department: Imperial College London, United Kingdom
Project Type: Laboratory
Project Field: Molecular Medicine, Cardiology
Authors: Lucia Chen, Valentina Caorsi, Chris Toepfer, Weihua Song, Steve Marston, Mike Ferenczi
Abstract
Introduction/Aims: Elucidating actomyosin interaction is key to understanding the molecular mechanisms of force generation in muscle. Although
the swinging lever arm hypothesis is widely accepted, the precise myosin-actin interactions at different stages of the power stroke are still unclear
and further studies of actomyosin complexes within functional muscle systems are required. Resolving these actomyosin interactions in cardiac
muscle is needed to further understand muscle contraction in the heart. Methods: We use Förster resonance energy transfer (FRET) to measure
nanometre distances between myosin and actin in functional cardiac muscle is described. In particular the interaction between the essential light
chain (ELC)-AlexaFluor488 (labelled at a single cysteine in position 180 of a modified ELC, exchanged with the native one) and ActinAlexaFluor594 Phalloidin is evaluated by the acceptor photobleaching method. In addition, we exploit FRET methods to measure the effect of
cardiac disease mutations, such as E99K, an actin mutation in a transgenic mouse model which in humans leads to hypertrophic cardiomyopathy.
Results: Our preliminary data suggests: i) E99K actin-mutation does not seem to affect the acto-myosin structures in terms of FRET efficiency
evaluated; ii) in contrast to skeletal fibres, the ELC-Actin distance in rigor cardiac fibres is within the range for FRET, indicating that cardiac and
skeletal muscle may possess differing cross-bridge conformations; iii) surprisingly, the ELC-Actin distance in relaxed cardiac fibres is approximately
1-2.5nm shorter than rigor-state distances. Conclusion: We successfully demonstrated that FRET has enough precision to detect nanometre-scale
variations in the actomyosin structure in different muscle environments and that FRET may be a useful tool to determine the structural effects of
disease-causing mutations at a molecular level.

19

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

The role of dyskerin in cardiac hypertrophy

abstracts

Name: Divya Nagarajan
University/ Trust/ Department: University of Manchester, United Kingdom
Project Type: Laboratory
Project Field: Heart Failure
Authors: Divya Nagarajan, Delvac Oceandy
Abstract
Heart failure (HF) is a common cardiovascular disease affecting 2% of adults and carries a poor prognosis as 30-40% of people diagnosed with HF
die within a year. Cardiac hypertrophy is an important stage in the development of HF and is characterised by an increase in the size of
cardiomyocytes and interstitial fibrosis. Previous studies have shown that cardiac hypertrophy and cancer pathways share similarities and also HF is
a metabolic disease and the metabolite pseudouridine is increased in the serum of patients with HF. By unifying these two strands to research the
protein dyskerin was selected for study as a possible target for new HF treatment. The dyskeratosis congenita-1 (DKC1) gene encodes for dyskerin
which functions as a pseudouridine synthase. Mutations in DKC1 gene leads to increased susceptibility to develop tumours. Pseudouridine is a
modified nucleoside that is formed after post-transcriptional modification of uridine and is a key constituent for mature and stable RNAs. In this
study, overexpression of DKC1 was compared against normal expression of DKC1 in neonatal rat cardiomyocytes to prove that elevated
pseudouridine levels correspond to increased cardiac hypertrophy. This was performed using immunofluorescence staining techniques to measure
cardiomyocyte size, luciferase assays to measure brain natriuretic peptide (BNP) expression and western blotting to measure protein levels. The
results indicated that DKC1 overexpression and therefore increased levels of dyskerin causes hypertrophy of neonatal rat cardiomyocytes. In
addition the results also suggest a novel finding that DKC1 might be involved in the upregulation of BNP in cardiomyocytes. In conclusion, this
study has shown that the protein dyskerin is involved in the development of cardiac hypertrophy and possibly upregulation of BNP in neonatal rat
cardiomyocytes. With further research, DKC1 gene regulation could be targeted as a possible new treatment option for HF.
The effect of TGF-β1 and BMP-4 on bone marrow derived stem cell morphology on a novel bioabsorbable nanocomposite
material for paediatric bypass graft application
Name: Hammad Lakhani
University/ Trust/ Department: University College London - Division of Surgery and Interventional Science, United Kingdom
Project Type: Laboratory
Project Field: Cardiovascular
Authors: Hammad Lakhnani, Achala de Mel, Alexander Seifalian
Abstract
Introduction: The incidence of congenital heart disease is 1.5 million worldwide, and often bypass grafts are needed as a treatment. In children, it is
essential that the graft can grow and so there has been a shift from prosthetic grafts towards developing completely tissue engineered blood vessels.
This study looks at using a bioabsorbable nanocomposite (POSS-PCL) polymer as scaffold in developing such a graft. The effects of the smooth
muscle cell inducing growth factors, TGF-β1 and BMP-4 on bone marrow derived stem cells (BMSCs) were analysed on POSS PCL scaffolds.
Methods: A new nanocomposite of POSS (polyhedral oligomeric silsesquioxane and PCL (poly(caprolactone-urea)urethane) was synthesized using a
solvent coagulation technique. 40 µm sodium bicarbonate particles were added to the polymer to produce a porous surface and BMSCs were seeded
onto the polymer by use of a micropipette. Alamar blue assays were used to assess growth of the cells on the polymer statically at serial time points.
Cell morphology was assessed using optical, confocal and scanning electron microscopy. Differentiation of cells to the smooth muscle cell lineage
was induced by the use of growth factors TGF-β1 and BMP-4. The phenotype of the cells was assessed using immunohistochemistry. Results: It was
found that growth factor induction led to a decrease in cell growth on POSS PCL as compared to the tissue culture plate control surface and confocal
microscopy analysis showed less cytoskeleton reorganization of these cells. After immunohistochemistry analysis, the BMSCs showed no
differentiation to smooth muscle cells. Conclusion: Growth factor induction on the static scaffold discs led to a change in morphology, with less
spreading of the cells, a lower proliferation rate and no differentiation into SMCs. These findings can be attributed to the POSS PCL being
manufactured by a coagulation technique, resulting in a structure with low stiffness.
Endothelial microparticles, inflammation and coagulation
Name: Joanna Hack
University/ Trust/ Department: University of Southampton, United Kingdom
Project Type: Laboratory
Project Field: Endocrinology and Metabolism
Authors: Joanna Hack, Nicola Englyst

20

Abstract
Background: Endothelial microparticles (EMP’s) are formed as a result of endothelial damage, which is the precursor to the majority of
cardiovascular disease (CVD), and can be initiated, by a variety of factors including inflammatory mediators and cardiovascular risk factors such as
smoking and hypercholesterolaemia. EMP’s have been shown to have detrimental pro-inflammatory and coagulative effects that promote CVD;
however, recent evidence suggests they also exert cytoprotective and anti-coagulant effects, via activated protein C (aPC). Aims: To optimise
thrombin generation and aPC generation assays. To use a variety of factors to stimulate human umbilical vein endothelial cells (HUVECs) to
produce EMPs. To compare aPC and thrombin generation on EMPs produced by different stimulation factors. Methods: HUVEC’s were grown to
confluence in vitro and then stimulated for 24 hours with either TNF-α (4ng/ml), IL-6 (80ng/ml), Thrombin (1 U/ml), serum starved medium,
Glucose (5mM) or Glucose (25mM). Preliminary experiments were also carried out using microvascular endothelial cells. EMP’s were then isolated
and washed via a centrifugation process. Thrombin and aPC generation assays were then performed on each of the EMP populations. EMP counts
and protein assays were also carried out as preliminary experiments. Results: Results show that EMP’s can generate both aPC and thrombin. The
stimulus for EMP release did not produce a statistically significant difference in this ability, however TNF-α appeared to reduce EMP aPC
production. This is supported by previous research on endothelial cells. EMP counts and protein assays provide interesting preliminary results.
Further research with EMP counts and expression of membrane proteins may help clarify these results and increase our understanding of EMP
function. Conclusions: The ability of EMPs to activate PC and thrombin, suggests they may play an important role in the development of CVD, but
may also as previously reported have beneficial cytoprotective effects.

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

The effect of neutrophil-derived microparticles on coronary artery endothelial cell activation

abstracts

Name: Robert Sandler
University/ Trust/ Department: University of Sheffield, United Kingdom
Project Type: Laboratory
Project Field: Acute Coronary Syndrome
Authors: RD Sandler, A Burnett, AC Morton, VC Ridger
Abstract
Background: Neutrophils are involved in the development and rupture of atherosclerotic plaques, which can lead to myocardial infarction.
Administration of anti-neutrophil antiserum reduces leukocyte rolling over plaques in vivo and an increased number of circulating neutrophils
exacerbates plaques. Furthermore, a complete depletion of neutrophils from the circulation reducing lesion area and macrophage content of
plaques. Leukocyte-derived microparticles have been found in plaques and are elevated in symptomatic cardiac patients. We investigated the role of
specifically neutrophil-derived microparticles (NDMP). Hypothesis: Neutrophil-derived microparticles (NDMP) from STEMI patients activate
coronary artery endothelial cells (CAEC) to a greater extent that NDMP from healthy volunteers (HV) in vitro. Methods: Neutrophils were isolated
from blood samples of STEMI patients (pre-treatment) and HV. They were stimulated with fMLP to produce microparticles, which were then
isolated and cultured with CAEC. Levels of inflammatory cytokines IL-6, IL-8 and MCP-1 were analysed by cytometric bead array at 30min, 2h, 4h &
24h. Electron microscopy was also carried out to image NDMP. Results: STEMI patients have a higher circulating neutrophil count than HV
(p<0.05) and NDMP from these patients appear to induce partial activation of CAEC in comparison (p=ns). Transport of blood on ice, prior to
neutrophil isolation, reduces microparticle production in response to fMLP-stimulation (p<0.01). Conclusion: Pre-analytical variables, such as
transport of blood on ice, have an effect on microparticle producton. Neutrophils are increased in STEMI and this may relate to increased activation
of CAEC. A population of NDMP are not homogenous and show variation in size and shape (<1µm).
Role of AMP-activated protein kinase (AMPK) in vascular endothelial protection
Name: Aamir Shamsi
University/ Trust/ Department: Imperial College London, United Kingdom
Project Type: Laboratory
Project Field: Vascular Sciences - Atherosclerosis
Authors: Aamir Shamsi
Abstract
Background: Adenosine monophosphate-activated protein kinase (AMPK), although known for its role in regulating cellular metabolism, has
recently emerged as an important kinase involved in vascular endothelial protection. We therefore investigated the hypothesis that AMPK activity is
important for the induction of the endothelial cytoprotective genes hem oxygenase-1 (HO-1), manganese superoxide dismutase (MnSOD) and
decay-accelerating factor (DAF). Methods: Human umbilical vein endothelial cells were exposed to factors known to alter AMPK activity including
shear stress, AICAR (an AMPK activator), a constitutively active form of AMPK delivered by adenovirus (Ad CA-AMPK), or the combination of
atorvastatin and rapamycin for 2 hours. EC were analysed by and either immunoblotting or flow cytometry. Transcription factor CREB was silenced
using siRNA. Results: In this study we showed that atherosclerosis prone patterns of oscillatory shear stress may be responsible for down-regulating
levels of active phospho-AMPK and HO-1. Cells treated with for 24 hours with AICAR had a significant increase in MnSOD, HO-1 and DAF protein
expression (p<0.05). Ad CA-AMPK was shown to deliver active forms of AMPK into the cells and this led to the induction of MnSOD, HO-1 and DAF
protein (p<0.05). We subsequently showed that increased AMPK activity leads to the activation and phosphorylation of CREB. Moreover, we found
that depletion of CREB with siRNA reduces MnSOD protein induction by Ad CA-AMPK. Finally, we found that this pathway could be activated by a
combination of atorvastatin and rapamycin which phosphorylated AMPK and induced DAF. Conclusion: We have shown that increased AMPK
activity in the endothelium induces the cytoprotective genes MnSOD, HO-1 and DAF. We have also suggested that CREB may be involved in this
pathway for AMPK-mediated induction of vasculoprotective genes and propose that AMPK and/or CREB represent potential therapeutic targets.
Questionnaire-based study into non-genetic factors of influence in hereditary haemorrhagic telangiectasia
Name: Budhi Maneesha Silva
University/ Trust/ Department: Imperial College London, United Kingdom
Project Type: Clinical
Project Field: Vascular Sciences
Authors: Buddhi Maneesha Silva
Abstract
Introduction: Epistaxis is the principal clinical presentation in 95% of hereditary haemorrhagic telangiectasia (HHT) cases. Nosebleed frequency
and severity are highly variable and not explained by gene mutation alone. Treatment of these patients remains challenging, with modalities ranging
from conservative therapies to invasive surgical procedures, whilst clinically significant reports of the influence of conservative therapies and
lifestyle variables on epistaxis remain largely anecdotal and poorly studied. This study aims to identify extraneous variables associated with HHTrelated epistaxis as reported by 649 HHT participants suffering from epistaxis. Methods: An online questionnaire-based study was carried out in
which participants were asked about previous specialist invasive treatments for their nosebleeds, various commonly used medical therapies in the
HHT population, other conservative treatments used for any purpose which influenced their nosebleeds and lastly lifestyle variables of influence.
Patients were asked to score treatments and variables, their responses converted into numerical format and statistical comparisons performed
where appropriate using GraphPad Prism. Results: The majority of participants reported the use of laser treatment and cautery, with mean scores of
0.98 and 0.42 respectively. Of the medical treatments specifically asked about, hormone and anti-hormone treatments displayed the greatest mean
scores of 0.22 and 0.53 respectively. The greatest positive/negative mean scores for self-reported treatments were for room humidification, saline
treatments and the Chinese herb Yunnan Baiyao (all 1.50) and acetylated salicylates (-1.79), anti-inflammatory drugs (-1.56) and omega-3 acids (1.20). 54 participants reported a provocative effect of foods high in salicylates on their nosebleeds. Conclusion: This study supports existing
evidence for the use of laser, cautery, hormones and anti-hormones and may provide evidence to suggest a preference for laser over cautery and
anti-hormones over hormones. HHT patients may be advised that the use of room humidification and nasal lubrication and avoidance of foods high
in salicylates is likely to improve nosebleeds

21

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

abstracts
Cardiac CT angiography – is it ready as a screening tool for coronary artery disease?
Name: Joanna Melgies
University/ Trust/ Department: University of Bristol
Project Type: Critical Discussion
Project Field: Coronary Artery Disease
Authors: Joanna Melgies
Abstract
Coronary Artery Disease (CAD) is the most common heart disease in the UK, affecting approximately 2.6 million people, nearly 25% of whom do not
experience symptoms. Currently, there are no screening programs for CAD. Cardiac CT Angiography (CCTA) has been suggested as a non-invasive
and reliable method of atherosclerotic plaque assessment with a potential to use in screening programs. For this programme to be successful, CCTA
should be able to clearly identify pre-clinical disease in an appropriate patient group with cardiovascular risk factors by determining the plaque
activity and thus its vulnerability. Once these criteria are achieved, a significant, cost-effective reduction in cardiovascular mortality and morbidity
needs to be proven. The project reveals current understanding of atherosclerotic plaque formation, explains the technological features of CCTA and
critiques this method in light of three of the WHO criteria for devising a screening programme – its ability to detect early stages of the disease, the
benefit versus risk balance and cost-effectiveness. Overall, it appears there is currently insufficient evidence to support use of CCTA in a screening
programme for coronary heart disease, however, with continued technology advancement this view will evolve.

The cost-effectiveness of cardiac MRI in the diagnosis and management of heart failure
Name: Edward Middleton
University/ Trust/ Department: Imperial College London, United Kingdom
Project Type: Clinical
Project Field: Health Economics Heart Failure
Authors: E Middleton, S Prasad
Abstract
Introduction: Heart failure is a condition with a high morbidity and mortality, affecting around 0.9% of the UK population. Its prevalence is rising due to an aging population and increased survival of acute coronary syndromes - and high costs are associated management. As a syndrome, heart
failure management requires identification of the aetiology and a treatment plan tailored to that case. Under guideline practice, this entails an
echocardiogram followed by subsequent follow-up tests. Through Gadolinium-based techniques and tissue characterisation, cardiac MRI can
provide detailed, accurate images of the failing heart. This study aimed to assess the cost-effectiveness of CMR in the diagnosis and management of
heart failure. Methods: This was done using a population of 25 patients with heart failure from the Royal Brompton Hospital, who had histories
presented to a panel of expert cardiologists. They were asked to create a management plan, based on information presented, which was entered into
a web program designed specifically for this study. Using NHS tariffs, the management plan costs were calculated and compared. Results: We found
that patients diagnosed using CMR-based protocols had management plans costing £301 more than standard protocols, on average. We found that
patients diagnosed with CMR had overall savings in the diagnosis phase, but increased costs in the treatment phase. These increased costs were as a
result of a greater number of patients being referred for revascularisation therapy: 25% vs 16% of cases. We also found that CMR increased the
proportion of these therapies that were PCI rather than CABG, from 14% to 47%. Conclusion: In conclusion, although the initial outlay may be more
costly, CMR may be more cost-effective in the diagnosis of heart failure than current guideline protocols. Increased costs were seen in the
management of patients, but this is due to a higher treatment rate among CMR-diagnosed patients.

22

Call 0845 900 0022
Email [email protected]
Online www.mps.org.uk/student

MEDICAL PROTECTION SOCIETY
PROFESSIONAL SUPPORT AND EXPERT ADVICE
FOUNDATION YEAR

MPS – the right choice
for your foundation year
because we put you first

Your choice of one FREE
Oxford Handbook
• 138C • 533C • 3278C

OXFORD HANDB

OOK OF

1 cARDiAc
2 RespiRAtORy
3 gAstROeNteR
OlOgicAl
4 ReNAl

Your essentia
l guide to the
management
of the acutel
acutelY ill patient

Acute meDiciNe

An established guide
to the management
acutely ill patient,
of the
this bestselling Handbook
been revised throughout
has
It relates pathophysiol for the third edition.
ogy to clinical features
help you make the
to
diagnosis quickly
and identify
priorities for treatment.
It provides step-by-step
management advice
for when you are
specialist help. The
awaiting
new
summary boxes detailingedition contains
management of common the key points in the
as well as a new chapter medical emergencies
on differential
diagnosis of common
specialist treatments presentations. Details of
make an informed are included to help you
decision about your
ongoing care.
patients’

OXFORD HANDBO

OK OF

Acu
A
cute meDiciN
e

5 sHOcK

We value your feedback.
Visit www.oup.co
m/uk/medicine/handboo
to give us your comments
ks
on this book

6 NeuROlOgicA
l
7 iNFectiOus DiseAses
8 Hiv-pOsitive
pAtieNts

Ramrakha
Moore
Sam

9 eNDOcRiNe

• TH

N
IO

EDIT
RD

and exPert advice

for new doctors

your lEading MEdicolE

gal journal

FREE New Doctor magazine

www.mps.org.uk
General enquiries (UK)
Tel 0845 605 4000
Fax 0113 241 0500
Email [email protected]
MPS Education and Risk Management
MPS Education and Risk Management is a dedicated division
providing risk management education, training and consultancy.
Tel 0113 241 0696
Fax 0113 241 0710
Email [email protected]
Please direct all comments, questions or suggestions
about MPS service, policy and operations to:

www.mps.org.uk

Chief Executive
Medical Protection Society
33 Cavendish Square, London W1G 0PS, United Kingdom

for
the MPS guide ts
medical studen

In the interests of confidentiality please do not include information
in any email that would allow a patient to be identified.

W1G 0Ps
MPS1228: 04/11
square, london
Society
at 33 cavendish
as set out in the
in england no. 36142
the Medical Protection
of MPs are discretionary
by guarantee. registered
a company limited
benefits of membership
company. all the
MPS1228_EthicsGuide_Cover.indd 1
MPs is not an insurance of association.
articles
Memorandum and

A map for the moral maze

Please direct all comments,
questions or suggestion
about MPs service,
s
policy and operations
to:
Chief Executive
Medical Protection
society
33 cavendish square,
london W1G 0Ps,
united Kingdom
decisions
the right
Making
in the interests of
confidentiality please
do not include information
in any email that
s
would allow aeekend
w patient to behandover
weekend
identified.

Inside this issue:

2
Moving from f1 to f2

the Medical Protection
professional indemnity society is the leading provider of
comprehensive
professionals around and expert advice to doctors, dentists
the world.
and health
MPs is not an insurance
company. all the
are discretionary
benefits of membership
as set out in the Memorandum
of MPs
and articles of association.
the Medical Protection
society limited. a
company limited
registered in england
by guarantee.
no. 36142 at 33
cavendish square,
london, W1G 0Ps.

www.mps.org.uk

a right to refuse?

AdvAnce decisions

And suicidAl PAtients

does the suit fit?
risks of working with
others
selecting the right

hoW Poor doctor–do

medicAl indemnity

ctor communicAtion

MEdical protEction
ction soci
sociEty
professIonAl support
A
And
expert

AdVIce

Preparing for
your F1 post

Poses risks

www.mps.org.uk

an MPS guide

to know

The Medical Protection Society
A company limited by guarantee. Registered in England no. 36142 at 33 Cavendish Square, London W1G 0PS
MPS is not an insurance company. All the benefits of membership of MPS are discretionary as set out in the
Memorandum and Articles of Association.

What you need

(UK)
0845 605 4000
0113 241 0500
[email protected]

yoUr F1 PoSt

www.facebook.com/
MPSmedicalstudent

Membership enquiries
t 0845 718 7187
F 0113 243 0500
g.uk
e [email protected]

Chief Executive
society
Medical Protection
33 cavendish square,
united Kingdom
london W1G 0Ps,
confidentiality please
in the interests of
in any email
do not include information to be identified.
a patient
allow
would
that

39 George Street, Edinburgh, EH2 2HN

PreParinG For

Medicolegal enquiries
t 0845 605 4000
F 0113 241 0500
e [email protected]

PAge 12

MPS education
and risk Managem
ent
MPs education and
g in anaesthetics
risk
orking
workin
nt is a dedicated
providing risk manageme Manageme
casE
division
nt education, training
PAGE 10
rts
and consultancy.
t 0113 241 0696
rEpo 17
F
0113 241 0710
p ge
pA
e [email protected]

Granary Wharf House, Leeds LS11 5PY

, questions or
Please direct all comments
MPs service, policy
suggestions about
and operations to:

Guide to Ethics – A map for the moral maze

33 Cavendish Square, London W1G 0PS

General enquiries
t 0845 605 4000
F 0113 241 0500
e [email protected]

advice

Society

t
F
e

The Medical Protection Society

Student enquiries
t 0845 900 0022
F 0113 241 0500
e [email protected]

Medical Protection
Society
So
Professional
suPPort and exPert

Why you might not
be right first time

General enquiries

tweets at:
follow our timely
ctors
www.twitter.com/MPSdo

al Services
MPS education
providing risk
a dedicated division
training and
management, education,
consultancy.
t 0113 241 0696
e [email protected]

Medical Protection

70

www.mps.org.uk

tun
tu
nn
ne
ell vision

33 cavendish square
london, W1G 0Ps
Granary Wharf House
leeds, ls11 5PY
39 George street
edinburgh, eH2 2Hn

While you
ing
sleep
to Ethics
re Guide
weMPS

publications,
visit our website for
other information:
news, events and
www.mps.org.uk

london W1G 0Ps
33 cavendish square,
leeds ls11 5PY
Granary Wharf House,
edinburgh, eH2 2Hn
39 George street,

Medical Protection
Society
Professional
suPPort and exPert
advice
MEDICAL PROTECTION SOCIETY
PROFESSIONAL SUPPORT AND EXPERT ADVICE

unitEd
d kingdoM

MEDICAL PROTECTION SOCIETY
PROFESSIONAL SUPPORT AND EXPERTnADVICE
Society
advice
Medical Protectio
suPPort and exPert
Professional

unitEd kingdoM

FroM
Get the MoSt
iP
your MPS MeMberSh

n Society
advice
Medical Protectio
suPPort and exPert
Professional

MEDICAL PROTECTION SOCIETY

Join us on facebook
ook

LIK
E
OUR PA
PAGE
GE

EDIT
RD
I



EDIT

3

• TH
I

FREE Preparing for your
F1 post guide

D
IR

N
IO



Professional suPPort

| mAY 2011

Working overseas?
Membership can usually
be arranged.

| mAY 2011



Volume 19 | Issue 2

FREE communications
courses and workshops

Volume 19 | Issue 2



on differential diag
diagnosis

All FREE benefits subject to receipt of
completed Direct Debit instruction

2011 | uNITeD KINGDom

FREE Casebook
– MPS’s flagship journal

a single source for
the most up-to-date
therapies
and protocols
contains
contains summary
boxes throughou
t highlighting
key points for treatment
iincludes
ncludes a new chapter

2

2011 | uNITeD KINGDom



Amir Sam

9 780199 230921

Volume 4 | Issue 1 |

FREE e-learning modules
on our website

EDIT

3

ISBN 978-0-19-9
23092-1

Volume 4 | Issue 1 |



‘This book is a no-nonsense
presentations and guides guide to acute
presentation of, causes you succinctly through the
of
stepwise plan of action and (most importantly) a
for common acute
Medic World
scenarios.’

• TH
I

Renew your MPS membership for your
F1 year for only £10 and receive:

D
IR

ON

icAl

N
IO

‘This pocket-sized
book
of information on acute contains an absolute wealth
medical problems
very comprehensive
and is
in
Hospital Doctor the breadth of its coverage.’

11 RHeumAtOlOg

12 DeRmAtOlOg
icAl
13 psycHiAtRic
14 DRug OveRDOses
15 pRActicAl
pROceDuRes
16 DiFFeReNtiAl
DiAgNOsis

| Kevin P. Moore |

editions:

• TH

Reviews of previous

10 HAemAtOlOg
icAl

Punit S. Ramrakha

www.mps.org.uk
www.mps.org.uk

www.mps.org.uk
13/10/2011 09:58

06/04/2011 08:24

MPs1344: 10/11

MPS1344

and student
Fitness to practise

dd 1

member guide_Cover.in

The Medical Protection Society Limited – A company limited by guarantee. Registered in England No. 36142 at 33 Cavendish Square,
London W1G 0PS, UK. MPS is not an insurance company. The benefits of membership are discretionary – this allows us the flexibility
to provide help and support even in unusual circumstances. Calls to Membership Services may be recorded for monitoring and
training purposes. MPS1374/UK: 07/12

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

delegate information
Southampton General Hospital

Southampton General Hospital is the home
of the University of Southampton's Faculty
of
Medicine.
University
Hospitals
Southampton NHS Foundation Trust is one
of the largest acute trusts in England. The
Wessex Cardiac Unit is a nationally and
internationally
renowned
centre
of
excellence. The department boasts worldleading experts in many fields of
cardiovascular medicine. Established in
1972, it serves a population of around 2.8
million, and is mainly based in the £60m state-of-the-art North Wing at
Southampton General Hospital. The cardiac care services cater to more than three
million people in central southern England and the Channel Islands.
 

24

The Undergraduate Journal of Cardiovascular Medicine: 1st edition, November 2012.

delegate information
Transportation
Train
Southampton Central train station is well served by trains from most
of the UK's major cities. Uni-link's U6H bus runs between
Southampton Central Station and the General Hospital every 20
minutes.
 

Coach
National Express and Greyhound both operate coach services from
Southampton. Coaches stop at either the Central coach station, or at
the University. From the coach station it is a short walk to
Southampton Central train station. Uni-link's U6H bus runs between
Southampton Central Station and the General Hospital every 20
minutes.

Car
Paid parking is available at Southampton General Hospital, however
free parking is available at the University's Highfield Campus. Unilink's U6H bus runs between Highfield Interchange and the General
Hospital every 20 minutes.
Air
Southampton Airport connects Southampton with many other UK and
European cities.

Accommodation
Several B&B's and hotels are located close to the hospital, or a short
bus ride away in the city centre.

23

Us
e S ou Get
JT r SJ 10
12 T %
at res of
th ou f
e c rce
he .
ck
ou
t.

Situational Judgement
Test – Prepare now!
NEW from onExamination, our Situational Judgement Test (SJT) resource assesses the presence
of the appropriate professional attributes expected of a UK foundation doctor. As with your
Education Performance Measure (EPM), your SJT performance provides 50% of the overall
score for your foundation application. Use our ranking five actions and select three from eight
question types to ensure you are prepared for this new test.
Our SJT resource offers:

• Over 100 ranking five and select three
from eight questions

• Aligned to the UK Foundation Programme’s
person specification

• Work Smart revision to answer questions
by type or curriculum area

• Performance feedback to assess your
exam aptitude

Make sure you are prepared ahead of the
exams on 7th December 2012 and 7th
January 2013.
Go online and try our FREE questions today.

twitter.com/onExamination
facebook.com/onExamination.Students

onexamination.com/SJT

Sponsor Documents

Or use your account on DocShare.tips

Hide

Forgot your password?

Or register your new account on DocShare.tips

Hide

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close